South African regulators decided Vertex Pharmaceuticals has provided sufficient access to its cystic fibrosis medications, ...

HHMI will bar institutions that already have two or more beneficiaries of its Investigator Program from applying for funds to ...

Editas plans to lay off 65% of its staff — around 180 employees — as it shelves its lead gene-editing program for sickle cell ...

Shelby Kinsey lives with a rare, fast-progressing form of ALS — but she has to spend her precious time fighting for insurance ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...